Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
暂无分享,去创建一个
Y. Nimura | K. Isse | Yasunori Sato | Y. Nakanuma | K. Harada | M. Sasaki | Y. Zen | A. Ishikawa | Shusaku Ohira | K. Oda | K. Kozaka
[1] K. Syrigos,et al. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer , 2004, British Journal of Cancer.
[2] M. Marino,et al. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. , 1999, Cancer research.
[3] T. Springer,et al. Expression of Stromal-Derived Factor-1 Is Decreased by IL-1 and TNF and in Dermal Wound Healing1 , 2001, The Journal of Immunology.
[4] K. Tsuneyama,et al. Enhanced expression of basement‐membrane‐type heparan sulfate proteoglycan in tumor fibro‐myxoid stroma of intrahepatic cholangiocarcinoma , 2001, Pathology international.
[5] Séverine Brulé,et al. Syndecan‐4 is a signaling molecule for stromal cell‐derived factor‐1 (SDF‐1)/ CXCL12 , 2005, The FEBS journal.
[6] M. Imamura,et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] M. Basik,et al. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. , 2004, Journal of leukocyte biology.
[8] A. Foussat,et al. Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Allavena,et al. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4 , 2004, Cancer Research.
[10] G. Cunha,et al. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma. , 1991, Cancer research.
[11] A. Balazs,et al. The pattern of cytokine gene expression in human colorectal carcinoma , 2008, Pathology & Oncology Research.
[12] Xiaochong Wu,et al. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. , 2003, Cancer research.
[13] 中村 孝夫. Induction of Hepatocyte Growth Factor in Fibroblasts by Tumor-derived Factors Affects Invasive Growth of Tumor Cells : In Vitro Analysis of Tumor-Stromal Interactions , 1998 .
[14] Y. Nakanuma,et al. Relationship between interleukin‐6 and proliferation and differentiation in cholangiocarcinoma , 1998, Histopathology.
[15] Masahiro Kato,et al. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma , 2003, Breast Cancer Research.
[16] G. Kollias,et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. , 1999, Nature medicine.
[17] F. Balkwill,et al. Epithelial cancer cell migration: a role for chemokine receptors? , 2001, Cancer research.
[18] K. Nackaerts,et al. Heparan sulfate proteoglycan expression in human lung‐cancer cells , 1997, International journal of cancer.
[19] 勝彦 齋藤,et al. ヒト肝内胆管癌の株化(CCKS1)樹立 , 1993 .
[20] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[21] Thomas A. Mustoe, MD, FACS,et al. Effect of age and hypoxia on TGFβ1 receptor expression and signal transduction in human dermal fibroblasts: Impact on cell migration , 2002, Journal of cellular physiology.
[22] J. Hirabayashi,et al. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. , 2001, Human pathology.
[23] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[24] F. Balkwill. Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.
[25] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[26] M. Apuzzo,et al. Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas. , 1993, Neurosurgery.
[27] M. Basik,et al. Evidence for the involvement of SDF‐1 and CXCR4 in the disruption of endothelial cell‐branching morphogenesis and angiogenesis by TNF‐α and IFN‐γ , 2004 .
[28] D. Polk,et al. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. , 1997, Gastroenterology.
[29] K. Tsuneyama,et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. , 2003, Gastroenterology.
[30] H. Yoshida,et al. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. , 2004, International journal of oncology.
[31] W. Gong,et al. Chemokines and their role in tumor growth and metastasis. , 1998, Journal of immunological methods.
[32] K. Matsumoto,et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. , 1997, Cancer research.
[33] M. Marino,et al. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. , 1999, Cancer research.
[34] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[35] M. Miyazaki,et al. Cholangiocarcinoma: Recent progress. Part 2: Molecular pathology and treatment , 2002, Journal of gastroenterology and hepatology.
[36] P. Lorigan,et al. TNF-α increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes , 2003, British Journal of Cancer.
[37] L. Chung,et al. The role of stromal-epithelial interaction in normal and malignant growth. , 1995, Cancer surveys.
[38] G. Gores,et al. Inhibition of interleukin 6–mediated mitogen‐activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line , 1999, Hepatology.
[39] G. Jayson,et al. Heparan sulfate proteoglycans and cancer , 2001, British Journal of Cancer.
[40] Y. Harabuchi,et al. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] G. Gores,et al. Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells , 2004, Cancer Research.
[42] M. Probst-Kepper,et al. CXCR4/CXCL12 expression and signalling in kidney cancer , 2002, British Journal of Cancer.
[43] D. Polk,et al. Conversion of TNFα from Antiproliferative to Proliferative Ligand in Mouse Intestinal Epithelial Cells by Regulating Mitogen-Activated Protein Kinase , 1999 .
[44] Gordon Stamp,et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. , 2002, Cancer research.
[45] M. Miyazaki,et al. Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology , 2002, Journal of gastroenterology and hepatology.
[46] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[47] Stefania Forti,et al. New insights into the role of extracellular matrix during tumor onset and progression , 2002, Journal of cellular physiology.
[48] D. Polk,et al. Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase. , 1999, Experimental cell research.
[49] M. Reiss,et al. Tumor necrosis factor stimulates epithelial tumor cell motility. , 1991, Cancer research.
[50] Y. Harabuchi,et al. Expression of CXCR4 and Its Down-Regulation by IFN-γ in Head and Neck Squamous Cell Carcinoma , 2005, Clinical Cancer Research.
[51] M. Washington,et al. TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.
[52] G. Murphy,et al. Molecular characterization of CXCR–4: A potential brain tumor‐associated gene , 1998, Journal of surgical oncology.
[53] Y. Nakanuma,et al. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[54] K. Isse,et al. Lipopolysaccharide Activates Nuclear Factor-KappaB through Toll-Like Receptors and Related Molecules in Cultured Biliary Epithelial Cells , 2003, Laboratory Investigation.
[55] G. Watanabe,et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer , 2001, British Journal of Cancer.
[56] V. Wee Yong,et al. CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.
[57] T. Bando,et al. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma , 2004, Laboratory Investigation.
[58] K. Tsuneyama,et al. Distribution of intrahepatic mast cells in various hepatobiliary disorders , 1998, Virchows Archiv.
[59] Y. Shiratori,et al. Stromal Cell–Derived Factor-1 from Biliary Epithelial Cells Recruits CXCR4-Positive Cells: Implications for Inflammatory Liver Diseases , 2003, Laboratory Investigation.
[60] Y. Nakanuma,et al. Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. , 2003, Human pathology.
[61] T. Ratliff. TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .